Transitional Epithelium (Urothelium): Structure, Function, and Clinical Significance

Transitional epithelium (urothelium) lines the urinary tract from renal calyces to proximal urethra. It is a specialized stratified epithelium uniquely adapted to cyclic distension and urinary toxicity.

Histologic Features

  • Basal Layer: Cuboidal, proliferative (stem/progenitor cells).
  • Intermediate Layer: Polyhedral; expands during filling.
  • Superficial (Umbrella) Cells: Large, dome-shaped, binucleated; plaques (uroplakins Ia, Ib, II, III) form crystalline membrane — impermeability barrier.

Key Functional Adaptations

  • Accommodation: Cells slide past each other; umbrella cells flatten → surface area ↑ 2–3× without tight junction rupture.
  • Impermeability: Uroplakin plaques + GAG layer prevent urea, ammonia, toxin back-diffusion; maintain osmotic gradient.
  • Barrier Defense: Tight junctions, antimicrobial peptides (ribonuclease 7, β-defensins), exfoliation of infected cells.
  • Sensory Signaling: Express TRPV1, P2X3, TRPA1 — detect stretch, ATP, pH → convey fullness, pain.

Clinical Relevance

  • Urothelial Carcinoma: 90% of bladder cancers; also upper tract. Risk: smoking, aromatic amines, cyclophosphamide, aristolochic acid.
  • Cystitis: Bacterial adherence to uroplakins (FimH binding); GAG layer defect in IC/BPS.
  • Stones / Obstruction: Epithelial injury → metaplasia (squamous, glandular) → dysplasia.
  • Cyclophosphamide Hemorrhagic Cystitis: Acrolein metabolite toxic to urothelium; prevented by mesna/hydration.

Urothelium is not passive lining—it is a dynamic, sensorimotor barrier central to urinary health and disease.

Urinary Disorders - Related Articles